Trials
Search / Trial NCT06438640

Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)

Launched by UNIVERSITY OF PENNSYLVANIA · May 23, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Recruiting

Keywords

Hip Fracture Femoral Neck Intertrochanteric Subtrochanteric Fracture Anesthesia Observational Study Survey Shared Decision Making My Anesthesia Choice Mac Hf

ClinConnect Summary

This clinical trial is studying a new way to improve discussions between patients and doctors about anesthesia options for hip fracture surgery. The goal is to help patients make better-informed decisions about their care. The study will use a simple one-page guide to help doctors communicate more effectively with their patients, along with some brief training for the doctors. This approach will be tested in six hospitals over 27 months to see how well it works.

To participate in this trial, you need to be 50 years or older and planning to have surgery for a hip fracture. However, if you have certain medical conditions that prevent you from safely receiving spinal anesthesia (a type of anesthesia given in the lower back), you won't be able to join the study. If you are eligible, you can expect to engage in better conversations about your anesthesia choices, which can help you feel more confident and involved in your treatment.

Gender

ALL

Eligibility criteria

  • Inclusion:
  • • Age 50 and older Planned surgery to treat a hip fracture
  • Exclusion:
  • • Contraindication to spinal anesthesia: current anticoagulant therapy or coagulopathy Contraindication to spinal anesthesia: critical aortic stenosis Contraindication to spinal anesthesia: skin infection over the lumbar spine

Trial Officials

Mark Neuman, MD

Principal Investigator

University of Pennsylvania

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Detroit, Michigan, United States

Winston Salem, North Carolina, United States

Lebanon, New Hampshire, United States

Philadelphia, Pennsylvania, United States

Gainesville, Florida, United States

Cleveland, Ohio, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0